Medicare will move ostomy supplies to eight national contracts in 2028. Survivors and clinicians say a poor fit can lead to leaks, infection and hospital stays.
|Articles|May 14, 2021
Watch Our Facebook Live on Clinical Trial Basics
Listen
0:00 / 0:00
Key Takeaways
- A first-time live-stream initiative was deployed to broaden access to clinical trial education within the kidney cancer community.
- Moderation by a genetic counselor–trained Medical Director supported clear framing of trial basics, including participation considerations.
Last week, the KCA hosted its very first live streaming event! The KCA’s Medical Director Sallie McAdoo, MS, CGC, moderated a Facebook Live conversation on the basics of clinical trials.
Advertisement
Last week, the KCA hosted its very first live streaming event! The KCA’s Medical Director Sallie McAdoo, MS, CGC, moderated a Facebook Live conversation on the basics of clinical trials. To help lend expertise, two members of the KCA’s Patient and Caregiver Advisory Council – John Ferrell and Peggy Zuckerman – spoke about their personal experiences participating in clinical trials for kidney cancer and what insights and lessons they’d learned. Watch the live event, then
Advertisement
Related to this article
An experimental treatment has kept one patient with heavily pretreated hairy cell leukemia free of detectable disease for more than two years, raising questions about whether CAR T-cell therapy could offer a path toward a cure.
The National Comprehensive Cancer Network released its first patient guideline written for caregivers on Oct. 27, 2026. The free guide covers emotional support, money, legal questions, medical tasks and caregivers' own well-being.
Three phase 3 trials presented at the 2026 ESMO Congress looked closely at swallowing, daily functioning and blood counts in throat, kidney and colorectal cancer. Here is what they found about living well during and after treatment.
New research found that nearly 1 in 5 second-level appeals for denied cancer medications under Medicare Part D were successful, raising questions about how insurers make coverage decisions and what patients can do when their treatment is denied.
Joy Maulik, MSN, FNP-C, explains why a prostate cancer diagnosis should be seen as a change in direction, not an ending, and how patients can lean on education, their providers and caregivers.
Dr. Morana Vojnic answers common questions about brain cancer, including diagnosis, tumor types, treatment effects, recurrence and life after treatment begins.
A national survey study of about 200,000 adults, published in Supportive Care in Cancer, found that people caring for someone with cancer had 89% higher odds of frequent mental distress than people who were not caregivers.
Advertisement
Advertisement
Trending on CURE
1
3 Quality-of-Life Results From ESMO 2026 Patients Should Know
2
4 Long-Term Survival Results From ESMO 2026 Patients Should Know
3
3 ESMO 2026 Results in Endometrial and Breast Cancer to Know
4
Neuro-Oncologist Answers Common Questions About Brain Cancer Diagnosis and Treatment
5